Search
Autolus Therapeutics PLC
AUTLAdd to Watchlist
1.490USD
-0.040-2.61%
Close 07-31 16:00（ET）Quotes delayed by 15 min
396.57MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Mon, Apr 20
Updated: Mon, Apr 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BioNTech SE
12.52%
Syncona Investment Management Limited
11.55%
MAK Capital One, LLC
11.27%
Clarus Ventures, LLC
7.70%
Blackstone Inc.
7.70%
Other
49.26%
Shareholders
Shareholders
Proportion
BioNTech SE
12.52%
Syncona Investment Management Limited
11.55%
MAK Capital One, LLC
11.27%
Clarus Ventures, LLC
7.70%
Blackstone Inc.
7.70%
Other
49.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor
23.99%
Hedge Fund
21.10%
Corporation
12.52%
Private Equity
9.43%
Venture Capital
8.01%
Investment Advisor/Hedge Fund
7.75%
Sovereign Wealth Fund
5.64%
Holding Company
5.55%
Research Firm
1.64%
Other
4.36%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
239
209.95M
78.88%
-50.13M
2025Q4
230
194.47M
90.55%
+128.60K
2025Q3
237
202.34M
94.14%
-20.86M
2025Q2
235
223.88M
91.00%
-2.80M
2025Q1
228
230.12M
90.84%
-11.63M
2024Q4
235
229.60M
92.37%
-10.27M
2024Q3
225
234.01M
89.22%
+30.38M
2024Q2
227
202.70M
79.95%
+2.45M
2024Q1
217
200.05M
58.18%
+45.35M
2023Q4
191
140.21M
76.10%
+4.14M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Syncona Investment Management Limited
30.73M
11.55%
+30.73M
--
Sep 30, 2024
MAK Capital One, LLC
30.01M
11.27%
+3.99M
+15.33%
Dec 31, 2025
Clarus Ventures, LLC
20.49M
7.7%
--
--
Sep 30, 2025
Blackstone Inc.
20.49M
7.7%
+20.49M
--
Dec 31, 2025
Armistice Capital LLC
17.50M
6.58%
+1.90M
+12.18%
Dec 31, 2025
Syncona Portfolio Ltd
16.64M
6.25%
--
--
Dec 31, 2025
Qatar Investment Authority
15.00M
5.64%
--
--
Mar 01, 2025
PPF Group N.V.
14.78M
5.55%
+170.00K
+1.16%
Oct 24, 2024
Polygon Management Ltd.
9.50M
3.57%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.56%
Virtus LifeSci Biotech Clinical Trials ETF
0.49%
ALPS Medical Breakthroughs ETF
0.17%
iShares Health Innovation Active ETF
0.07%
ProShares Ultra Nasdaq Biotechnology
0.03%
Invesco Nasdaq Biotechnology ETF
0.03%
iShares Biotechnology ETF
0.02%
SPDR S&P International Small Cap ETF
0.01%
Tema Oncology ETF
0%
Fidelity Fundamental Small-Mid Cap ETF
0%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.56%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.49%
ALPS Medical Breakthroughs ETF
Proportion0.17%
iShares Health Innovation Active ETF
Proportion0.07%
ProShares Ultra Nasdaq Biotechnology
Proportion0.03%
Invesco Nasdaq Biotechnology ETF
Proportion0.03%
iShares Biotechnology ETF
Proportion0.02%
SPDR S&P International Small Cap ETF
Proportion0.01%
Tema Oncology ETF
Proportion0%
Fidelity Fundamental Small-Mid Cap ETF
Proportion0%